Zimmer Biomet Holdings Inc Revenue Growth Rates (ZBH), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Zimmer Biomet Holdings Inc   (NYSE: ZBH)
 

ZBH's Revenue Growth by Quarter and Year

Zimmer Biomet Holdings Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/ZBH/growth
https://api.csimarket.com/api/v1/companies/ZBH/fundamentals
https://api.csimarket.com/api/v1/companies/ZBH/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
ZBH Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 2,062.90
2nd Quarter June 2,177.00
1st Quarter March 2,086.70
FY 6,326.60

ZBHs Annual Revenue
Zimmer Biomet Holdings Inc 's Revenue in the fiscal year 2025 $ 8,231.50 millions
Zimmer Biomet Holdings Inc 's Revenue in the fiscal year 2024 $ 7,678.60 millions
Zimmer Biomet Holdings Inc 's Revenue in the fiscal year 2023 $ 7,394.20 millions
Zimmer Biomet Holdings Inc 's Revenue in the fiscal year 2022 $ 6,939.90 millions
Zimmer Biomet Holdings Inc 's Revenue in the fiscal year 2021 $ 7,836.20 millions




ZBH Revenue third quarter 2026 Y/Y Growth Comment
Zimmer Biomet Holdings Inc reported Revenue growth of 3.07% year on year in the third quarter 2026, to $ 2,062.90 millions, this is lower than Zimmer Biomet Holdings Inc 's recent average Revenue growth of 5.07%.

Looking into third quarter 2026 results within Medical Equipment & Supplies industry 137 other companies have achieved higher Revenue growth. While Zimmer Biomet Holdings Inc ' s Revenue increase of 3.07% ranks overall at the positon no. 2592 in the third quarter 2026.


ZBH Revenue ( Y/Y Growth %) 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 3.07 %
2nd Quarter June 4.8 %
1st Quarter March 9.3 %
FY   -

Financial Statements
Zimmer Biomet Holdings Inc 's third quarter 2026 Revenue $ 2,062.90 millions ZBH's Income Statement
Zimmer Biomet Holdings Inc 's third quarter 2025 Revenue $ 2,001.40 millions Quarterly ZBH's Income Statement


ZBH Revenue (Quarter on Quarter Growth %)

 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -5.24 %
2nd Quarter June 4.33 %
1st Quarter March -7 %
FY (Year on Year)   -


Back to ZBH Growth rate Comparisons >> Back to ZBH Growth rate Comparisons >>


Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #138
Healthcare Sector #374
Overall #2592

Revenue Y/Y Growth Statistics
High Average Low
62.67 % 5.07 % -12 %
(Jun 30 2016)   (Dec 31 2020)
Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #138
Healthcare Sector #374
Overall #2592
Revenue Y/Y Growth Statistics
High Average Low
62.67 % 5.07 % -12 %
(Jun 30 2016)   (Dec 31 2020)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Zimmer Biomet Holdings Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
57.35 % 1.67 % -31.26 %
(Sep 30 2020)  


ZBH's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2026 Zimmer Biomet Holdings Inc disclosed decline in Revenue from the second quarter by -5.24% to $ 2,062.90 millions, from $ 2,177.00 millions achived in the previous reporting period.

But that's not important problem, as Zimmer Biomet Holdings Inc 's Revenue generally seem to plunge in this quarter.

Within Medical Equipment & Supplies industry 49 other companies have achieved higher Revenue quarter on quarter growth. While Zimmer Biomet Holdings Inc 's Revenue growth quarter on quarter, overall rank is 1212.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #50
Healthcare Sector #178
Overall #1212
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #50
Healthcare Sector #178
Overall #1212
Revenue Q/Q Growth Statistics
High Average Low
57.35 % 1.67 % -31.26 %
(Sep 30 2020)  


ZBH's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2026 Zimmer Biomet Holdings Inc disclosed decline in Revenue from the second quarter by -5.24% to $ 2,062.90 millions, from $ 2,177.00 millions achived in the previous reporting period.

But that's not important problem, as Zimmer Biomet Holdings Inc 's Revenue generally seem to plunge in this quarter.

Within Medical Equipment & Supplies industry 49 other companies have achieved higher Revenue quarter on quarter growth. While Zimmer Biomet Holdings Inc 's Revenue growth quarter on quarter, overall rank is 1212.


Zimmer Biomet Holdings Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending (Mar 31 2026) 12 Months Ending (Dec 31 2025) 12 Months Ending (Sep 30 2025) 12 Months Ending (Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 8,508.80
Y / Y Revenue Growth (TTM) 8.62 %
Year on Year Revenue Growth Overall Ranking # 2262
Seqeuential Revenue Change (TTM) 1.19 %
Seq. Revenue Growth (TTM) Overall Ranking # 2592


Cumulative Revenue growth Comment
Assuming the Zimmer Biomet Holdings Inc 's fiscal year would have ended in Jun 30 2026, Zimmer Biomet Holdings Inc would have reprted above average annual Revenue improvement of 8.62% year on year, of $ 8,509 millions.
This marks a slow-down of the companys growth trends and from the 9.23% growth in Mar 31 2026.

In the Healthcare sector 329 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1634 to 2262.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 138
Healthcare Sector # 330
Overall # 2262

Revenue TTM Y/Y Growth Statistics
High Average Low
62.67 %
 5.07 %
-12 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 138
Sector # 374
S&P 500 # 2592
Cumulative Revenue growth Comment
Assuming the Zimmer Biomet Holdings Inc 's fiscal year would have ended in Jun 30 2026, Zimmer Biomet Holdings Inc would have reprted above average annual Revenue improvement of 8.62% year on year, of $ 8,509 millions.
This marks a slow-down of the companys growth trends and from the 9.23% growth in Mar 31 2026.

In the Healthcare sector 329 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1634 to 2262.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 138
Healthcare Sector # 330
Overall # 2262

Revenue TTM Y/Y Growth Statistics
High Average Low
62.67 %
5.07 %
-12 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 138
Sector # 374
S&P 500 # 2592




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
ZBH's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue growth for the quarter ending Sep 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2026
Universal Health Services Inc 5.30%$ 5.297 millions
Acadia Healthcare Company Inc 5.14%$ 5.136 millions
Lumexa Imaging Holdings Inc 5.03%$ 5.032 millions
Bio techne Corp4.75%$ 4.753 millions
Merck and Co Inc 4.68%$ 4.683 millions
Davita Inc 4.62%$ 4.617 millions
Sotera Health Company4.61%$ 4.613 millions
Avantor Inc 4.59%$ 4.588 millions
Icu Medical Inc4.39%$ 4.388 millions
Illumina Inc 4.15%$ 4.151 millions
Agenus Inc4.14%$ 4.144 millions
United Therapeutics Corporation4.13%$ 4.128 millions
Option Care Health Inc 4.09%$ 4.086 millions
Henry Schein Inc 3.95%$ 3.953 millions
Grail Inc 3.71%$ 3.705 millions
Docgo Inc 3.70%$ 3.702 millions
Hca Healthcare Inc 3.59%$ 3.591 millions
Collegium Pharmaceutical Inc 3.43%$ 3.427 millions
Healthcare Services Group Inc 3.29%$ 3.288 millions
Cytek Biosciences Inc 3.26%$ 3.255 millions
Zimmer Biomet Holdings Inc 3.07%$ 3.073 millions
Ardent Health Inc 3.05%$ 3.051 millions
Bioventus Inc 3.05%$ 3.048 millions
Infusystem Holdings Inc3.02%$ 3.017 millions
Integra Lifesciences Holdings Corp2.27%$ 2.268 millions
Align Technology inc 1.97%$ 1.966 millions
Pediatrix Medical Group Inc 1.72%$ 1.724 millions
Lantheus Holdings Inc 1.71%$ 1.708 millions
10x Genomics Inc 1.59%$ 1.591 millions
Bruker Corporation1.58%$ 1.581 millions


About Zimmer Biomet Holdings Inc Revenue Growth Rates (ZBH), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Zimmer Biomet Holdings Inc (CIK 1136869).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001193125-26-447203
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Zimmer Biomet Holdings Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.